Skip to main content

Advertisement

Log in

Decreased Levels of Circulating CD4+CD25+Foxp3+ Regulatory T Cells in Patients with Primary Antiphospholipid Syndrome

  • Brief Communication
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Introduction

CD4+CD25+Foxp3+ regulatory T (Treg) cell dysfunction has been documented in various autoimmune disorders, but not in antiphospholipid syndrome (APS) so far.

Methods

In this cross-sectional study, we aim to investigate CD4+CD25+Foxp3+ Treg cells, CD3+CD19 T cells and CD3CD19+ B cells in patients with primary APS and healthy controls. Cell subtypes were immunophenotyped using specific monoclonal antibodies (anti-CD3 CY5, anti-CD4 FITC, anti-CD25, anti-Foxp3, anti-CD19 PE) and flow cytometry.

Results

Twenty patients with APS and 20 age- and sex-matched controls were studied. The percentage of total lymphocytes, activated Th cells (CD4+CD25+), Treg cells and CD3CD19+ B cells were found significantly lower in APS patients as compared to controls (all p < 0.05).

Conclusion

A dysfunction in CD4+CD25+Foxp3+ Treg cells may represent one of the mechanisms leading to autoimmunity in APS patients. The decreased number of CD3CD19+ B cells of APS patients warrants further elucidation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Palomo IG, Segovia FM, Alarcon ML, Fuentes BY, Pereira JG, Rojas A, et al. An insight into the pathophysiology of thrombosis in antiphospholipid syndrome. Front Biosci. 2007;12:3093–103.

    Article  PubMed  CAS  Google Scholar 

  2. López-Pedrera C, Buendía P, Aguirre MA, Velasco F, Cuadrado MJ. Antiphospholipid syndrome and tissue factor: a thrombotic couple. Lupus. 2006;15:161–6.

    Article  PubMed  Google Scholar 

  3. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8–27.

    Article  PubMed  CAS  Google Scholar 

  4. Yamaguchi T, Wing JB, Sakaguchi S. Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. Semin Immunol. 2011;23:424–30.

    Article  PubMed  CAS  Google Scholar 

  5. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6.

    Article  PubMed  CAS  Google Scholar 

  6. Valencia X, Lipsky PE. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol. 2007;3:619–26.

    Article  PubMed  CAS  Google Scholar 

  7. D’Hennezel E, Bin Dhuban K, Torgerson T, Piccirillo C. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2012;49:291–302.

    Article  PubMed  Google Scholar 

  8. Peterson RA. Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol. 2012;40:186–204.

    Article  PubMed  CAS  Google Scholar 

  9. Bernard F, Romano A, Granel B. Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjögren’s syndrome. Rev Med Interne. 2010;31:116–27.

    Article  PubMed  CAS  Google Scholar 

  10. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.

    Article  PubMed  CAS  Google Scholar 

  11. Moon HW, Kim BH, Park CM, Hur M, Yun YM, Kim SY, Lee MH. CD4+CD25highFoxP3+ regulatory T-cells in hematologic diseases. Korean J Lab Med. 2011;31(4):231–7.

    Article  PubMed  CAS  Google Scholar 

  12. Willis R, Harris EN, Pierangeli SS. Pathogenesis of the antiphospholipid syndrome. Semin Thromb Hemost. 2012;38:305–21.

    Article  PubMed  CAS  Google Scholar 

  13. Meroni PL, Gerosa M, Raschi E, Scurati S, Grossi C, Borghi MO. Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss. Clin Rev Allergy Immunol. 2008;34:332–7.

    Article  PubMed  Google Scholar 

  14. Loser K, Beissert S. Regulatory T cells: banned cells for decades. J Invest Dermatol. 2012;132(3 Pt 2):864–71.

    Article  PubMed  CAS  Google Scholar 

  15. Gómez-Puerta JA, Martín H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, et al. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore). 2005;84:225–30.

    Article  Google Scholar 

  16. Genre J, Errante PR, Kokron CM, Toledo-Barros M, Câmara NO, Rizzo LV. Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity? Clin Immunol. 2009;132:215–21.

    Article  PubMed  CAS  Google Scholar 

  17. Hoehlig K, Shen P, Lampropoulou V, Roch T, Malissen B, O’Connor R, et al. Activation of CD4+Foxp3+ regulatory T cells proceeds normally in the absence of B cells during EAE. Eur J Immunol. 2012;42:1164–73.

    Article  PubMed  CAS  Google Scholar 

  18. Kuhn A, Beissert S, Krammer PH. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res. 2009;301:71–81.

    Article  PubMed  Google Scholar 

  19. Alunno A, Bartoloni E, Bistoni O, Nocentini G, Ronchetti S, Caterbi S, et al. Balance between Regulatory T and Th17 cells in systemic Lupus Erythematosus: the old and the new. Clin Dev Immunol. 2012;2012:823085.

    Article  PubMed  Google Scholar 

  20. Chen RL, Tao Y, Qiu KW, Huang WH, Huang CH, Li J. Association of circulating Treg cells with disease activity in patients with rheumatoid arthritis. Nan Fang Yi Ke Da Xue Xue Bao. 2012;32(6):886–9.

    PubMed  Google Scholar 

  21. Torres-Aguilar H, Blank M, Kivity S, Misgav M, Luboshitz J, Pierangeli SS, et al. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4+ T cell response to β2GPI. Ann Rheum Dis. 2012;71:120–8.

    Article  PubMed  CAS  Google Scholar 

  22. Thompson JA, Perry D, Brusko TM. Autologous regulatory T cells for the treatment of type 1 diabetes. Curr Diab Rep. 2012. [Epub ahead of print].

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henrique Luiz Staub.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dal Ben, E.R.R., do Prado, C.H., Baptista, T.S.A. et al. Decreased Levels of Circulating CD4+CD25+Foxp3+ Regulatory T Cells in Patients with Primary Antiphospholipid Syndrome. J Clin Immunol 33, 876–879 (2013). https://doi.org/10.1007/s10875-012-9857-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-012-9857-y

Keywords

Navigation